DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...
Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
Glucotrack has successfully completed a first-in-human study with its continuous glucose monitor (CGM) that directly measures ...
The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...
The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...
Monitoring of the body’s blood sugar is essential to the treatment of diabetes. But getting effective glucose readings has ...
Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...
Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance ...
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
Trinity Biotech (TRIB) stock gains on encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose ...
For athletes with diabetes, continuous glucose monitors are game-changers, helping them avoid dangerous blood sugar crashes ...